More Company News

Mereo BioPharma

Pricing of $100m Public Offering of ADS
10 Feb 2021Read More

Mereo BioPharma

Setrusumab partnership with Ultragenyx
17 Dec 2020Read More

Mereo BioPharma

Update on AIM delisting and agreements with SVB and Kreos Capital
15 Dec 2020Read More

Mereo BioPharma

Appointment of SVP of Clinical Development
23 Nov 2020Read More

Mereo BioPharma

Intended cancellation of AIM listing
11 Nov 2020Read More

Mereo BioPharma

Additions to management team
20 Oct 2020Read More

Mereo BioPharma

FDA clearance for Phase Ib/II etigilimab anti-TIGIT study
19 Oct 2020Read More

Mereo BioPharma

Registration statement filed with US SEC
07 Oct 2020Read More

Mereo BioPharma

Interim H120 results and corporate update
29 Sep 2020Read More

Mereo BioPharma

Additions and changes to board
28 Sep 2020Read More

1 2 3 4 5
Return to Mereo BioPharma
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).